Institutional Manager · CIK 0001747821
Decheng Capital Management III (Cayman), LLC
Grand Cayman, E9 · File #028-22474
Latest AUM
$312.9M
Positions
27
Top-10 Concentration
79.2%
Filings
3
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | Alpine Immune Sciences, Inc. | 010392595 | +6,708,288 | +$76.8M | $0 |
| NEW | Zentalis Pharmaceuticals Inc. | 98943L107 | +2,099,583 | +$42.1M | $0 |
| NEW | Aura Biosciences, Inc. | 05153U107 | +1,163,123 | +$18.2M | $0 |
| NEW | ROIVANT SCIENCES LTD | 00BMW4NZ9 | +1,459,700 | +$17.0M | $0 |
| NEW | ACELYRIN INC(NSM) | 00445A100 | +1,548,317 | +$15.7M | $0 |
| NEW | Arcus Biosciences, Inc | 03969F109 | +869,790 | +$15.6M | $0 |
| NEW | 10x Genomics, Inc. | 88025u109 | +359,554 | +$14.8M | $0 |
| NEW | Argenx SE | 04016x101 | +27,429 | +$13.5M | $0 |
| NEW | Everest Medicines Limited | 44975P103 | +4,166,667 | +$13.3M | $0 |
| NEW | Pacific Biosciences of California, Inc. | 69404D108 | +1,463,872 | +$12.2M | $0 |
Filing History
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202326 pos · $299.6M
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202327 pos · $312.9M
- 13F HOLDINGS REPORTQ/E Dec 202327 pos · $312.9M
Top 20 Holdings — Dec 2023
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Alpine Immune Sciences, Inc. | 02083G100 | 6,708,288 | $76.8M | 25.63% |
| 2 | Zentalis Pharmaceuticals Inc. | 98943L107 | 2,099,583 | $42.1M | 14.06% |
| 3 | Aura Biosciences, Inc. | 05153U107 | 1,163,123 | $18.2M | 6.09% |
| 4 | ROIVANT SCIENCES LTD | G76279101 | 1,459,700 | $17.0M | 5.69% |
| 5 | ACELYRIN INC(NSM) | 00445A100 | 1,548,317 | $15.7M | 5.26% |
| 6 | Arcus Biosciences, Inc | 03969F109 | 869,790 | $15.6M | 5.21% |
| 7 | 10x Genomics, Inc. | 88025u109 | 359,554 | $14.8M | 4.95% |
| 8 | Argenx SE | 04016x101 | 27,429 | $13.5M | 4.50% |
| 9 | Pacific Biosciences of California, Inc. | 69404D108 | 1,463,872 | $12.2M | 4.08% |
| 10 | Illumnia, Inc. | 452327109 | 80,859 | $11.1M | 3.70% |
| 11 | LANTHEUS HOLDINGS INC(NMS) | 516544103 | 142,196 | $9.9M | 3.30% |
| 12 | Horizon Therapeutics PLC | G46188101 | 78,900 | $9.1M | 3.05% |
| 13 | PHATHOM PHARMACEUTICALS INC | 71722W107 | 850,000 | $8.8M | 2.94% |
| 14 | IMMUNOGEN INC | 45253H101 | 415,880 | $6.6M | 2.20% |
| 15 | SEAGEN INC | 81181C104 | 23,014 | $4.9M | 1.63% |
| 16 | Cue Health Inc. | 229790100 | 8,980,909 | $4.0M | 1.32% |
| 17 | BeyondSpring Inc. | G10830100 | 4,958,143 | $4.0M | 1.32% |
| 18 | Terns Pharmaceuticals, Inc. | 880881107 | 714,285 | $3.6M | 1.20% |
| 19 | Equillium Inc. | 29446K106 | 4,447,308 | $3.3M | 1.10% |
| 20 | Aadi Bioscience, Inc. | 00032Q104 | 526,329 | $2.5M | 0.85% |